These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 7360009)
1. The effect of oral contraceptives on mononuclear cell cholesteryl ester hydrolase activity. Hagemenas FC; Yatsu FM; Manaugh LC Lipids; 1980 Jan; 15(1):39-44. PubMed ID: 7360009 [TBL] [Abstract][Full Text] [Related]
2. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring. Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404 [TBL] [Abstract][Full Text] [Related]
3. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162 [TBL] [Abstract][Full Text] [Related]
4. Effect of oral contraceptives on plasma androgenic steroids and their precursors. Fern M; Rose DP; Fern EB Obstet Gynecol; 1978 May; 51(5):541-4. PubMed ID: 148599 [TBL] [Abstract][Full Text] [Related]
5. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins. Goldzieher JW; de la Peña A; Chenault CB; Cervantes A Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928 [TBL] [Abstract][Full Text] [Related]
6. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial. Notelovitz M; Kitchens CS; Khan FY Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974 [TBL] [Abstract][Full Text] [Related]
7. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment. Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073 [TBL] [Abstract][Full Text] [Related]
8. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles. Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353 [TBL] [Abstract][Full Text] [Related]
9. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency. Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796 [TBL] [Abstract][Full Text] [Related]
10. A quantitative study of the pregnancy zone protein in sera of woman taking oral contraceptives. Damber MG; von Schoultz B; Solheim F; Stigbrand T Am J Obstet Gynecol; 1976 Feb; 124(3):289-92. PubMed ID: 55075 [TBL] [Abstract][Full Text] [Related]
11. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives. Spellacy WN Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):732-4. PubMed ID: 7039318 [TBL] [Abstract][Full Text] [Related]
12. Cyclic fluctuations in human serum lipid and apolipoprotein levels during the normal menstrual cycle: comparison with changes occurring during oral contraceptive therapy. Lussier-Cacan S; Xhignesse M; Desmarais JL; Davignon J; Kafrissen ME; Chapdelaine A Metabolism; 1991 Aug; 40(8):849-54. PubMed ID: 1907348 [TBL] [Abstract][Full Text] [Related]
13. Effect of oral alanine loads on plasma amino acids in oral contraceptive users and control women. Potera C; Rose DP Am J Clin Nutr; 1978 May; 31(5):794-8. PubMed ID: 645627 [TBL] [Abstract][Full Text] [Related]
14. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol. Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785 [TBL] [Abstract][Full Text] [Related]
15. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones. Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418 [TBL] [Abstract][Full Text] [Related]
16. Sex hormone binding globulin: effect of synthetic steroids on the assay and effect of oral contraceptives. Bowles SM; Mills RJ Ann Clin Biochem; 1981 Jul; 18(Pt 4):226-31. PubMed ID: 7197136 [TBL] [Abstract][Full Text] [Related]
17. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy. Rosenfeld WE; Doose DR; Walker SA; Nayak RK Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594 [TBL] [Abstract][Full Text] [Related]
18. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids. Scott JA; Brenner PF; Kletzky OA; Mishell DR Am J Obstet Gynecol; 1978 Apr; 130(7):817-21. PubMed ID: 345817 [TBL] [Abstract][Full Text] [Related]
19. [Effect of oral contraceptive on the pituitary and plasma L.H. levels and on the hypothalamic LH-RH level (author's transl)]. Sato N; Yanaihara T; Kanazawa M; Okinaga S; Arai K Nihon Naibunpi Gakkai Zasshi; 1976 Aug; 52(8):845-50. PubMed ID: 797581 [TBL] [Abstract][Full Text] [Related]
20. Effects on sex hormone binding globulin of different oral contraceptives containing norethisterone and lynestrenol. Odlind V; Weiner E; Victor A; Johansson ED Br J Obstet Gynaecol; 1980 May; 87(5):416-21. PubMed ID: 6155933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]